UniHealth Hospitals Limited (formerly known as Unihealth Consultancy Limited) has released its investor presentation for the financial year ended March 31, 2026, marking a defining chapter in its journey toward becoming a global leader in healthcare delivery. The results showcase a company in high-growth mode, characterized by robust revenue expansion, nearly doubled bed capacity, and a successful entry into the Indian hospital market.
Financial Performance: Growth Meets Efficiency
The fiscal year 2026 was a standout year for UniHealth’s balance sheet. The company reported a 34.61% year-on-year (YoY) increase in Total Income, reaching ₹137.01 crore. More significantly, disciplined operational execution led to an 82.87% YoY surge in Net Profit (PAT), which climbed to ₹25.83 crore.
Key FY2026 Financial Highlights at a Glance:
- Total Income: ₹137.01 Cr (up from ₹101.79 Cr in FY25).
- EBITDA: ₹58.82 Cr, representing a 48.91% YoY growth.
- EBITDA Margin: Expanded to 42.93% (up from 38.80% in FY25).
- Earnings Per Share (EPS): ₹16.52.
- Three-Year Trajectory: Revenue has grown 3x from ₹43.94 crore in FY23 to ₹131.99 crore in FY26.
A Transformational Year in Africa
UniHealth continues to leverage its strong foothold in the African market, which remains its primary revenue engine, accounting for 84.13% of total revenue in FY26. A major highlight of the year was the successful acquisition and commissioning of UMC Hospital in Entebbe, Uganda. This move added 30 beds, bringing the company’s total Uganda network capacity to 150 beds and strengthening its “Hub-and-Spoke” model between Entebbe and Kampala.
Other regional milestones include:
- The delivery of the first IVF-conceived twins at UMC Victoria Hospital, marking a significant achievement for its specialized reproductive medicine department.
- Continued operations at the 80-bed UMC Zhahir Hospital in Kano, Nigeria, and the UniHealth Medical Centre in Mwanza, Tanzania.
Strategic India Entry: The Navi Mumbai Launch
While Africa remains a core strength, FY26 marked UniHealth’s boldest move into the Indian market with the commissioning of a 60-bed tertiary care multi-specialty hospital in Navi Mumbai. Equipped with advanced diagnostics, modular operating theaters, and a cardiac cath lab, this facility serves as the first of five-plus planned hospitals across Western India.
The company’s India strategy focuses on an asset-light model, primarily targeting leased properties for boutique surgical hospitals to ensure high EBITDA margins.
A Diversified Healthcare Ecosystem
UniHealth’s resilience stems from its four synergistic business verticals:
- Medical Centres & Hospitals: The primary growth driver.
- Pharmaceutical Distribution: Exporting medical consumables from India to African nations like Uganda, Nigeria, and Tanzania.
- Healthcare Consultancy: Managing over 1,300 beds in projects under consultancy, offering end-to-end design and management services.
- Medical Value Travel (MVT): Facilitating seamless travel for African patients seeking specialized care in a network of 50+ leading Indian hospitals.
The Roadmap to FY2027
Under the leadership of founders Dr. Akshay Parmar and Dr. Anurag Shah, UniHealth has set ambitious targets for the near future. The company’s strategic roadmap includes:
- Targeting a total capacity of 1,000 beds within the next three years.
- Adding 120 beds in Tanzania and progressing with hospital projects in Nashik and Pune.
- A financial target for FY27 of ₹300+ crore in revenue.
With its successful listing on the NSE Emerge platform and a clear focus on underserved, high-growth markets, UniHealth is positioning itself as a “one-stop healthcare solution provider”. By bridging the healthcare gap between Africa and India, the company is not only driving shareholder value but also fulfilling its vision of providing affordable, world-class medical services.
Disclaimer: This post is based on UniHealth Hospitals Limited’s H2 & FY26 Investor Presentation dated June 3, 2026.